Codex Helps Amgen Focus on Patients

Why It Matters

By reducing time spent on repetitive coding and speeding analysis, CodeX could shorten development cycles and improve decision-making, potentially accelerating therapies to patients and increasing R&D productivity. Widespread, cumulative AI gains can materially lower costs and heighten competitive advantage in biopharma.

Summary

Amgen employees say GitHub Copilot/CodeX is freeing scientists and engineers from routine coding tasks so they can focus on research and patient outcomes. The tool accelerates data analysis by translating prompts into structured analyses and delivering articulated insights with business context. Users report that these incremental efficiencies across teams compound into significant organizational impact. The company views AI not as a single large investment but as many small, distributed improvements that together enhance drug development.

Original Description

"The ability to abstract away from the tedious boring bits of writing code and to spend your energy thinking about patients, that's where Codex is making the biggest impact at Amgen," Sean Bruich.

➡️ https://lnkd.in/dnxrM282